Login to Your Account

New biotech spinoff emerges from Anhui Anke, Shanghai Newsummit ¥55M JV

By Cornelia Zou
Staff Writer

Wednesday, March 5, 2014

HONG KONG – A Chinese biotechnology company is leading a group of investors, including many of its own top executives, in a joint venture to develop a sought-after drug used to regenerate skin cells in burn victims.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription